Neuromeka Statistics

Total Valuation

Neuromeka has a market cap or net worth of KRW 354.09 billion. The enterprise value is 395.11 billion.

Market Cap	354.09B
Enterprise Value	395.11B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Neuromeka has 11.35 million shares outstanding. The number of shares has increased by 4.92% in one year.

Current Share Class	11.35M
Shares Outstanding	11.35M
Shares Change (YoY)	+4.92%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	20.15%
Owned by Institutions (%)	0.06%
Float	9.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	18.50
PB Ratio	24.98
P/TBV Ratio	25.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-19.50
EV / Sales	20.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-17.67

Financial Position

The company has a current ratio of 0.78, with a Debt / Equity ratio of 4.00.

Current Ratio	0.78
Quick Ratio	0.44
Debt / Equity	4.00
Debt / EBITDA	n/a
Debt / FCF	-2.54
Interest Coverage	-2.87

Financial Efficiency

Return on equity (ROE) is -155.17% and return on invested capital (ROIC) is -14.79%.

Return on Equity (ROE)	-155.17%
Return on Assets (ROA)	-10.82%
Return on Invested Capital (ROIC)	-14.79%
Return on Capital Employed (ROCE)	-34.93%
Revenue Per Employee	132.00M
Profits Per Employee	-139.72M
Employee Count	n/a
Asset Turnover	0.22
Inventory Turnover	2.19

Taxes

In the past 12 months, Neuromeka has paid 24.84 million in taxes.

Income Tax	24.84M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +40.86% in the last 52 weeks. The beta is 1.18, so Neuromeka's price volatility has been higher than the market average.

Beta (5Y)	1.18
52-Week Price Change	+40.86%
50-Day Moving Average	28,344.00
200-Day Moving Average	25,849.00
Relative Strength Index (RSI)	59.50
Average Volume (20 Days)	192,554

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Neuromeka had revenue of KRW 19.14 billion and -20.26 billion in losses. Loss per share was -1,836.68.

Revenue	19.14B
Gross Profit	2.61B
Operating Income	-15.23B
Pretax Income	-20.25B
Net Income	-20.26B
EBITDA	-12.52B
EBIT	-15.23B
Loss Per Share	-1,836.68

Full Income Statement

Balance Sheet

The company has 15.72 billion in cash and 56.72 billion in debt, giving a net cash position of -41.00 billion or -3,612.54 per share.

Cash & Cash Equivalents	15.72B
Total Debt	56.72B
Net Cash	-41.00B
Net Cash Per Share	-3,612.54
Equity (Book Value)	14.17B
Book Value Per Share	1,247.46
Working Capital	-10.76B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -13.47 billion and capital expenditures -8.88 billion, giving a free cash flow of -22.36 billion.

Operating Cash Flow	-13.47B
Capital Expenditures	-8.88B
Free Cash Flow	-22.36B
FCF Per Share	-1,969.83

Full Cash Flow Statement

Margins

Gross margin is 13.62%, with operating and profit margins of -79.55% and -105.85%.

Gross Margin	13.62%
Operating Margin	-79.55%
Pretax Margin	-105.78%
Profit Margin	-105.85%
EBITDA Margin	-65.40%
EBIT Margin	-79.55%
FCF Margin	n/a

Dividends & Yields

Neuromeka does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.92%
Shareholder Yield	-4.92%
Earnings Yield	-5.72%
FCF Yield	-6.31%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Neuromeka has an Altman Z-Score of 0.74 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.74
Piotroski F-Score	2